2022-07-05-世界卫生组织-Immunization_Uruguay_2022_country_profile_16页_350kb

Uruguay Immunization Coverage Report: 2022 Summary

Key Points

• All estimates rely entirely on government-reported administrative data, with no independent assessments.
• Coverage levels remain high across multiple vaccines, though recent years show declining trends, potentially influenced by registry system changes.
• Recommendations state that high-quality independent empirical assessments are needed to verify reported levels.
• Numerator and denominator values declined from 2018 onward; data completeness and accuracy are not determined to be sufficient.

Doses Monitored by Vaccine

• BCG: Coverage ≥95% (estimate vs official: consistently 99%)
• DTP1/3: DTP3 coverage declined (89-96%) in some years, but estimates averaged >95%
• Pol3: Coverage fluctuated between 89-95%
• HepB (birth dose & third dose): Insufficient data provided
• Hib3: Coverage declined from 95% to 89%
• IPV1: Coverage dropped from 97% to 95%
• MCV1/2: MCV1 coverage ≥95% since 2017; MCV2 dropped from 92-95% to 84%, with data challenges
• RCV1: Coverage aligned with MCV1 estimates (no independent data)
• RotaC: No available estimates
• PcV3: Coverage remained at ~94-95% since 2012

Data Considerations

• Estimates tagged with labels (GoC), reflecting data source strengths (primary: official, administrative) with noted absence of representative surveys.
• All estimates are presented without classical uncertainty measures (confidence intervals) due to interpolation methods used.
• The level of confidence varies by year, with earlier years having higher confidence ratings.

Official Sources & Further Info

• This summary reflects the 2021 revision of data estimated through July 7, 2022.
• Full supplements are available at the linked WHO/UNICEF data portal.

Disclaimer

These estimates are provided for transparency and monitoring purposes and may not align with official national-level immunization data due to varying assessment methods.